Abel de la Rosa
Director/Board Member at VIRIOS THERAPEUTICS, INC.
Abel de la Rosa active positions
| Companies | Position | Start | End |
|---|---|---|---|
| VIRIOS THERAPEUTICS, INC. | Director/Board Member | 21/12/2020 | - |
| Independent Dir/Board Member | 21/12/2020 | - | |
Antios Therapeutics, Inc.
 Antios Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Antios Therapeutics, Inc. operates as a biopharmaceutical company devoted to developing therapies for viral diseases. The company was founded by Abel De La Rosa, Doug Mayers and Idean Marvasty on October 30, 2018 and is headquartered in Atlanta, GA. | Chairman | 01/12/2020 | - |
| Founder | - | - | |
| Director/Board Member | - | 01/12/2020 | |
| Chief Executive Officer | - | 01/12/2020 |
Career history of Abel de la Rosa
Former positions of Abel de la Rosa
| Companies | Position | Start | End |
|---|---|---|---|
Celtaxsys, Inc.
 Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Celtaxsys, Inc. operates as a clinical-stage drug discovery and development company that focuses on novel therapeutics to treat patients suffering from inflammatory diseases. It offers CTX-4430, a small-molecule drug that targets the enzyme Leukotriene A4 hydrolase in immune cells for the treatment of cystic fibrosis and moderately severe acne diseases. The company was founded by William P. Reddick in 2005 and is headquartered in Atlanta, GA. | Director/Board Member | 01/01/2012 | 01/01/2020 |
| Drug Innovation Ventures At Emory LLC | Chief Tech/Sci/R&D Officer | 01/01/2012 | 01/01/2018 |
Emory Institute For Drug Development
 Emory Institute For Drug Development Miscellaneous Commercial ServicesCommercial Services Emory Institute For Drug Development engages in drug discovery and development in industry and academia. It provides organization, facilities and resources to translate academic drug discovery into clinical candidates. The company was founded by Dennis C. Liotta in 2009 and is headquartered in Atlanta, GA. | Chief Tech/Sci/R&D Officer | 01/01/2012 | 01/01/2018 |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Chief Tech/Sci/R&D Officer | 01/01/2002 | 01/01/2012 |
Training of Abel de la Rosa
| University of California San Diego | Undergraduate Degree |
| Miami University | Doctorate Degree |
Statistics
International
| United States | 9 |
Operational
| Director/Board Member | 3 |
| Chief Tech/Sci/R&D Officer | 3 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| VIRIOS THERAPEUTICS, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Antios Therapeutics, Inc.
Antios Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Antios Therapeutics, Inc. operates as a biopharmaceutical company devoted to developing therapies for viral diseases. The company was founded by Abel De La Rosa, Doug Mayers and Idean Marvasty on October 30, 2018 and is headquartered in Atlanta, GA. | Health Technology |
Celtaxsys, Inc.
Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Celtaxsys, Inc. operates as a clinical-stage drug discovery and development company that focuses on novel therapeutics to treat patients suffering from inflammatory diseases. It offers CTX-4430, a small-molecule drug that targets the enzyme Leukotriene A4 hydrolase in immune cells for the treatment of cystic fibrosis and moderately severe acne diseases. The company was founded by William P. Reddick in 2005 and is headquartered in Atlanta, GA. | Health Technology |
| Drug Innovation Ventures At Emory LLC | |
Emory Institute For Drug Development
Emory Institute For Drug Development Miscellaneous Commercial ServicesCommercial Services Emory Institute For Drug Development engages in drug discovery and development in industry and academia. It provides organization, facilities and resources to translate academic drug discovery into clinical candidates. The company was founded by Dennis C. Liotta in 2009 and is headquartered in Atlanta, GA. | Commercial Services |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Health Technology |
- Stock Market
- Insiders
- Abel de la Rosa
- Experience
